June was a remarkable month for initial public offerings in the US by biopharmaceutical companies, since 14 have gone public so far this month – just one IPO short of the 15 offerings launched during the first five months of 2020. The most recent IPOs to hit the US market came from [Akouos Inc.], Fusion Pharmaceuticals Inc. and PolyPid Ltd. on 25 and 26 June.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?